Tag Archives: Maxwell Biosciences

New leadership to spearhead AI-driven breakthroughs in drug discovery and operational excellence Austin, Texas–(Newsfile Corp. – July 17, 2025) – Maxwell Biosciences (“Maxwell”), a global health technology company pioneering immune-inspired small molecules called Claromers™, today announced new engineering leadership for its Artificial Intelligence efforts—further cementing its decade-long commitment to AI-first …

U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology Austin, Texas–(Newsfile Corp. – March 5, 2025) – Maxwell Biosciences, a preclinical drug platform company that develops ClaromersTM, synthetic small molecules that mimic and improve upon the natural immune …

U.S. Naval Infectious Diseases Diagnostic Laboratory to study dengue fever activity of Claromer antiviral compounds, combatting a rapidly growing mosquito-borne viral infection and a national priority biodefense threat Austin, Texas–(Newsfile Corp. – February 26, 2025) – Maxwell Biosciences, a preclinical drug platform company that develops ClaromersTM, synthetic small molecules that …